Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: results of the prospective randomized SWITCH OVER trial
Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study